Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Rodgers Richard J Create: Alert

All | News | Filings
Date FiledTypeDescription
07/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/13/2023 3 Rodgers Richard J (Director) has filed a Form 3 on Sagimet Biosciences Inc.
06/16/2023 4 Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC.
Txns: Granted 18,494 shares @ $0
Granted 49,237 options to buy @ $3.92, valued at $193k
04/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2023 4 Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns: Granted 20,822 shares @ $0
11/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/01/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
10/04/2022 4 Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns: Exercised (in-or-at-the-money) 3,148 options to buy @ $0.0001, valued at $0.3
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2022 4 Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns: Granted 4,629 shares @ $0
01/05/2022 4 Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns: Granted 4,021 shares @ $0
10/04/2021 4 Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns: Granted 2,912 shares @ $0
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/25/2020 4 Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns: Bought 17,730 shares @ $0
Bought 26,789 options to buy @ $0
Bought 3,148 options to buy @ $0.0001, valued at $0.3
11/13/2020 4 Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns: Granted 50,000 options to buy @ $4.05, valued at $202.5k
11/09/2020 4 Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.
Txns: Granted 5,910 shares @ $0
06/11/2020 4 Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC.
Txns: Granted 9,233 shares @ $0
Granted 23,500 options to buy @ $7.31, valued at $171.8k
06/17/2019 4 Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC.
Txns: Granted 24,635 shares @ $0
Granted 50,000 options to buy @ $2.74, valued at $137k
06/07/2019 4 Rodgers Richard J (Director) has filed a Form 4 on REXAHN PHARMACEUTICALS, INC.
Txns: Granted 3,537 options to buy @ $5.23, valued at $18.5k
06/29/2018 4 Rodgers Richard J (Director) has filed a Form 4 on REXAHN PHARMACEUTICALS, INC.
Txns: Granted 39,742 options to buy @ $1.46, valued at $58k
06/15/2018 4 Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC.
Txns: Granted 16,749 shares @ $0
Granted 15,000 options to buy @ $4.03, valued at $60.5k
06/09/2017 4 Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC.
Txns: Granted 15,697 shares @ $0
Granted 15,000 options to buy @ $4.3, valued at $64.5k
04/12/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/10/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/06/2016 4 Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC.
03/08/2013 4 Rodgers Richard J (Executive VP & CFO) has filed a Form 4 on TESARO, Inc.
07/06/2012 4 Rodgers Richard J (Exec. Vice President & CFO) has filed a Form 4 on TESARO, Inc.
06/27/2012 3 Rodgers Richard J (EXECUTIVE VP AND CFO) has filed a Form 3 on TESARO, Inc.
07/15/2009 4 Rodgers Richard J (Senior Vice President and CFO) has filed a Form 4 on Abraxis BioScience, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy